Conditions: Gastroesophageal Junction Adenocarcinoma
Interventions: Drug: Tislelizumab; Drug: SKB315 for injection; Drug: Capecitabine
Sponsors: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Not yet recruiting Conditions: Gastroesophageal Junction Adenocarcinoma
Interventions: Drug: Tislelizumab; Drug: SKB315 for injection; Drug: Capecitabine
Sponsors: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Not yet recruiting
